Altasciences vs Certara

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/altasciences/certara

Category	Altasciences	Certara
Listed site	both	cro
Summary	Mid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities.	Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.
Services	Preclinical In Vivo Studies GLP Toxicology Safety Pharmacology In Vitro Pharmacology Phase I Clinical Trials Phase II Clinical Trials Clinical Trial Services Bioanalysis Ligand-Binding Bioanalysis (Large Molecule) Analytical Method Development & Validation ICH Stability Studies Biostatistics & Statistical Programming Data Management & eClinical Medical Writing Clinical Operations Regulatory Affairs In Vivo PK / PD Studies Preclinical In Vitro Studies Phase IV / Post-Marketing In Vitro ADME / DMPK Formulation Development Stability Testing & Storage	Biostatistics & Statistical Programming Data Management & eClinical Regulatory Affairs Medical Writing Computational & In-Silico Drug Discovery Translational Research Target Identification & Validation High-Throughput Screening Medicinal Chemistry In Vitro Pharmacology In Vitro ADME / DMPK Safety Pharmacology Genetic Toxicology Discovery Research In Vivo Efficacy Models In Vivo PK / PD Studies GLP Toxicology Preclinical In Vitro Studies Preclinical In Vivo Studies Bioanalysis LC-MS Bioanalysis (Small Molecule) Ligand-Binding Bioanalysis (Large Molecule) Phase I Clinical Trials Biomarker Assays Phase II Clinical Trials Phase III Clinical Trials Clinical Operations Phase IV / Post-Marketing US FDA Regulatory Strategy US FDA Regulatory Strategy EU EMA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy China NMPA Regulatory Strategy Clinical Trial Services
Modalities	Small Molecule Biologics (Other) Cell Therapy Gene Therapy	Small Molecule Small Molecule Biologics (Monoclonal Antibodies) Biologics (Monoclonal Antibodies) Biologics (Other) Biologics (Other) Peptide Peptide Oligonucleotide Oligonucleotide mRNA mRNA Antibody-Drug Conjugate (ADC) Antibody-Drug Conjugate (ADC) Gene Therapy Gene Therapy Cell Therapy Cell Therapy Vaccine Vaccine
Indications	Cardiovascular Dermatology Gastroenterology Immunology Infectious Disease Metabolic Neurology Oncology Ophthalmology Psychiatry Respiratory Women's Health	Oncology Rare Disease Immunology Immunology Neurology Neurology Psychiatry Metabolic Metabolic Cardiovascular Cardiovascular Infectious Disease Infectious Disease Respiratory Respiratory Dermatology Dermatology Ophthalmology Ophthalmology Gastroenterology Gastroenterology Nephrology Nephrology Women's Health Women's Health
Locations	Headquarters, Montreal, Quebec, Canada Bioanalytical Laboratory, Laval, Quebec, Canada Clinical Site, Montreal, Quebec, Canada Clinical and Research Campus, Overland Park, Kansas, United States Preclinical Testing, Everett, Washington, United States Manufacturing and Analytical Services, Harleysville, Pennsylvania, United States Preclinical Testing, Scranton, Pennsylvania, United States Preclinical Testing, Columbia, Missouri, United States Clinical Pharmacology, Cypress, California, United States Preclinical Testing, Sacramento, California, United States Laval, Laval, Quebec, Canada Overland Park, Overland Park, Kansas, United States Everett, Everett, Washington, United States Harleysville, Harleysville, Pennsylvania, United States Cypress, Cypress, California, United States Scott Township, Scott Township, Pennsylvania, United States Auxvasse, Auxvasse, Missouri, United States Sacramento, Sacramento, California, United States Canada, Canada, Canada United States, United States, United States Canada and U.S. operations	Global network Global presence, 30 countries Global presence, Multiple, 30 countries, Global Global presence, Multiple, 30+ countries Global presence, Multiple, 30 countries, International Headquarters, Radnor, Pennsylvania, United States Global presence, 30 countries Global presence, 30+ countries
Certifications	FDA · Identifier: FDA inspection passed 2001 GLP · Identifier: GLP Compliant GMP · Identifier: GMP Manufacturing	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.